Franklin Biotechnology Discv N Acc $

Performance History31/01/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv N Acc $
Fund101.247.739.5-28.13.9
+/-Cat6.23.6-4.10.90.5
+/-Idx-5.93.2-4.7-5.61.8
 
Key Stats
NAV
24/02/2017
 USD 26.11
Day Change 1.74%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0122613499
Fund Size (Mil)
31/01/2017
 USD 2283.77
Share Class Size (Mil)
31/01/2017
 USD 161.08
Max Initial Charge 3.00%
Ongoing Charge
27/01/2017
  2.59%
Investment Objective: Franklin Biotechnology Discv N Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns24/02/2017
YTD4.48
3 Years Annualised7.00
5 Years Annualised31.16
10 Years Annualised18.74
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
29/12/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv N Acc $31/10/2016
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks93.160.0093.16
Bonds0.000.000.00
Cash5.150.005.15
Other1.690.001.69
Top 5 Regions%
United States96.68
United Kingdom1.63
Middle East0.69
Eurozone0.57
Canada0.22
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.61
Biogen IncHealthcareHealthcare7.88
Tesaro IncHealthcareHealthcare7.33
Gilead Sciences IncHealthcareHealthcare7.28
Incyte CorpHealthcareHealthcare4.66
Franklin Biotechnology Discv N Acc $